PDCD1 and neoplasm: Injections of anti-PD1 antibodies as part of the treatment had no additional significant effect on reducing the tumor growth rate (P˃0.05 between CpG+αOX40 and CpG+αOX40+αPD1 groups) (Fig. 4A).